iShares US Pharmaceuticals ETF
IHE
IHE
97 hedge funds and large institutions have $348M invested in iShares US Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 92 → 97 (+5)
26% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 35
Holders
97
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$67.9M | |
| 2 | +$5.78M | |
| 3 | +$5.5M | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.48M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.09M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$9.02M | |
| 3 | -$6.69M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.73M |
| 5 |
TC
Telemus Capital
Southfield,
Michigan
|
-$2.31M |